The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
10X GENOMICS INC CL A COM 88025U109 18,696 300,000 SH   SOLE   300,000 0 0
89BIO INC COM 282559103 24,043 952,200 SH   SOLE   952,200 0 0
ADVERUM BIOTECHNOLOGIES INC COM 00773U108 9,715 994,381 SH   SOLE   994,381 0 0
AVADEL PHARMACEUTICALS PLC SPONS ADR 05337M104 8,399 1,057,827 SH   SOLE   1,057,827 0 0
AXSOME THERAPEUTICS INC COM 05464T104 47,652 810,000 SH   SOLE   810,000 0 0
CONSTELLATION PHARMACEUTICALS INC COM 210373106 126,250 4,016,873 SH   SOLE   4,016,873 0 0
INOVIO PHARMACEUTICALS INC COM NEW 45773H201 21,576 2,900,000 SH   SOLE   2,900,000 0 0
IVERIC BIO INC COM 46583P102 8,898 2,586,537 SH   SOLE   2,586,537 0 0
MARINUS PHARMACEUTICALS INC COM 56854Q101 13,201 6,502,840 SH   SOLE   6,502,840 0 0
MERSANA THERAPEUTICS INC COM 59045L106 15,297 2,623,903 SH   SOLE   2,623,903 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 799 113,140 SH   SOLE   113,140 0 0
RELMADA THERAPEUTICS INC COM 75955J402 28,748 842,814 SH   SOLE   842,814 0 0
SIERRA ONCOLOGY INC COM NEW 82640U404 4,822 491,017 SH   SOLE   491,017 0 0
SPERO THERAPEUTICS INC COM 84833T103 3,830 474,015 SH   SOLE   474,015 0 0
TRILLIUM THERAPEUTICS INC COM NEW 89620X506 27,432 6,790,000 SH   SOLE   6,790,000 0 0
VERASTEM INC COM 92337C104 9,823 3,720,930 SH   SOLE   3,720,930 0 0